The Effect of Thymoquinone on the Characteristics of the Brain Extracellular Space in Transient Middle Cerebral Artery Occlusion Rats.


Journal

Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984

Informations de publication

Date de publication:
2020
Historique:
entrez: 4 9 2020
pubmed: 4 9 2020
medline: 17 6 2021
Statut: ppublish

Résumé

The extracellular space (ECS) is the space between the neurons and the capillaries in the brain. The volume fraction (α) and the tortuosity (λ) are the main parameters used to describe its characteristics. Thymoquinone has been proved to possess anti-oxidant and anti-inflammatory activity. In this study, we used a gadolinium-diethylenetriaminepentacetate (Gd-DTPA)-enhanced magnetic resonance imaging (MRI) system to determine the effects of thymoquinone on ECS parameters in transient middle cerebral artery occlusion rats (tMCAO) to prove the neuroprotective effect of thymoquinone on brain tissue damage caused by ischemic stroke. Neurological examinations, 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin-eosin (H&E) staining and assaying of ECS parameters using MRI were performed 24 h after surgery. We found that thymoquinone could improve the behavioural performance by neurological examinations. TTC staining indicated that thymoquinone significantly decreased the percentage of hemi-cerebral infarction. Also, H&E staining showed that thymoquinone could inhibit the neuron necrosis in the hippocampal CA1 region. We found that thymoquinone treatment could inhibit the changes in ECS diffusion parameters, which might prove that thymoquinone might protect brain tissue damage caused by ischemic stroke. Thymoquinone can protect the brain against cerebral ischemia-reperfusion injury, effectively ameliorate abnormalities in characteristics of ECS and decrease cerebral infarction in tMCAO rats.

Identifiants

pubmed: 32879204
doi: 10.1248/bpb.b19-00991
doi:

Substances chimiques

Benzoquinones 0
Neuroprotective Agents 0
thymoquinone O60IE26NUF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1306-1314

Auteurs

Chaoxin Fan (C)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University.
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University.

Fang Tian (F)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University.
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University.

Xin Zhao (X)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University.
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University.

Yi Sun (Y)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University.
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University.

Xiaogai Yang (X)

Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University.

Hongbin Han (H)

Beijing Key Lab. of Magnetic Resonance Imaging Technology.

Xiaoping Pu (X)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University.
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH